CFDE Data Portal | Search nephropathy diabetic

	Label	Description
	PR000409 Project (Entity type)	Diabetic nephropathy (DN) is the leading cause of end stage renal disease, and is associated with hi...
	PR000410 Project (Entity type)	Diabetic nephropathy (DN) is the leading cause of end stage renal disease, and is associated with hi...
	PR001894 Project (Entity type)	Chronic kidney disease (CKD) is characterized by a gradual loss of kidney function and affects ca. 1...
	PR000395 Project (Entity type)	Diabetic nephropathy (DN) is the leading cause of end stage renal disease, and is associated with hi...
	PR001359 Project (Entity type)	Despite recent advances, diabetic nephropathy (DN) remains a major public health concern. The precis...
	Diabetic Nephropathy Disease Or Phenotype (Entity type)	A Disease Or Phenotype
	CHPT1 MOUSE Protein (Entity type)	Cholinephosphotransferase 1
	1-(3-Mercapto-2-methyl-propionyl)-pyrrolidine-2-carboxylic acid indication Diabetic Nephropathy Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	LOSARTAN indication Diabetic Nephropathy Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-(2-hydroxyethyl)-4-methyl-N-(4-(methylsulfonyl)phenyl)-5-(2-(trifluoromethyl)phenyl)-1H-pyrrole-3-carboxamide indication Diabetic Nephropathy Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

PR000409

Diabetic nephropathy (DN) is the leading cause of end stage renal disease, and is associated with hi...

PR000410

Diabetic nephropathy (DN) is the leading cause of end stage renal disease, and is associated with hi...

PR001894

Chronic kidney disease (CKD) is characterized by a gradual loss of kidney function and affects ca. 1...

PR000395

Diabetic nephropathy (DN) is the leading cause of end stage renal disease, and is associated with hi...

PR001359

Despite recent advances, diabetic nephropathy (DN) remains a major public health concern. The precis...

Diabetic Nephropathy

A Disease Or Phenotype

CHPT1 MOUSE

Cholinephosphotransferase 1

1-(3-Mercapto-2-methyl-propionyl)-pyrrolidine-2-carboxylic acid indication Diabetic Nephropathy

A Knowledge Graph Assertion from IDG

LOSARTAN indication Diabetic Nephropathy

A Knowledge Graph Assertion from IDG

1-(2-hydroxyethyl)-4-methyl-N-(4-(methylsulfonyl)phenyl)-5-(2-(trifluoromethyl)phenyl)-1H-pyrrole-3-carboxamide indication Diabetic Nephropathy

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.